Please note that the URL for this site has changed to a 'phe.org.uk' address from 'nhs.uk'. This reflects changes we have made to hosting for this site.
 
Current UK NSC recommendations > Human immunodeficiency virus

The UK NSC recommendation on Human Immunodeficiency Virus (HIV) screening in pregnancy

 
Recommendation Systematic population screening programme recommended
Last review completed July 2006
Next review due in n/a
 

Evidence to support continuation or cessation of existing screening programmes should be reviewed regularly. The process for this is currently being revised, which is why this topic does not currently have a review date. The new process will be published in due course. Each programme has an active portfolio of research, evidence and audit to support continual improvement. Find out more about human immunodeficiency screening as part of the infectious diseases screening programme in England.


Screening for HIV should be offered to all pregnant women to reduce the rate of mother to child transmission.

 

Find general information about population health screening.

More about Human immunodeficiency virus

Infection with the human immunodeficiency virus (HIV) results in progressive destruction of the immune system. As a result of this an infected individual becomes susceptible to a number of different infections and is also liable to become wasted and also to develop neurological problems.

» Read more about HIV on NHS Choices

Screening in the UK

Compare how screening is offered across the UK.

Stakeholders

British Association for Sexual Health and HIV
British HIV Association
British Society for Immunology
Halve It
Royal College of Obstetricians and Gynaecologists

The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.

More options

Go to top